re104
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 14, 2024 (NCT06342310)
Timeline
Indications
Mechanism of action
HTR2A agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07146191 | Phase 1 | Aug 19, 2025 | Reunion Neuroscience Inc |
| NCT07002034 | Phase 2 | Jul 30, 2025 | Reunion Neuroscience Inc |
| NCT06659263 | Phase 1 | Nov 13, 2024 | Reunion Neuroscience Inc |
| NCT06342310 | Phase 2 | Jun 14, 2024 | Reunion Neuroscience Inc |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Reunion Neuroscience Inc | For profit | 4 | 4 | 2 | 2024 |
1 organizations
Page 1 / 1